Tag: risk minimisation

Understanding Additional Risk Minimisation Measures for Marketing Authorisation Holders Key Takeaways Additional risk minimisation measures (aRMMs) are crucial for ensuring patient safety and effective communication of risks associated with specific medicinal products. Implementing aRMMs requires a tailored approach that considers the specific risk profile of the product and its target…

Understanding Additional Risk Minimisation Measures for Marketing Authorisation Holders Key Takeaways Additional risk minimisation measures (aRMMs) are critical tools for managing the safety profile of medicinal products. Effective implementation of aRMMs requires thorough planning and continuous monitoring to ensure compliance with regulatory requirements. Regular communication with stakeholders, including regulatory authorities…